| 1 |
Shouval R, Fein JA, Labopin M, et al. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis[J]. Lancet Haematol, 2019, 6(11):e573-e584.
|
| 2 |
Barker JN, Kurtzberg J, Ballen K, et al. Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies[J]. Biol Blood Marrow Transplant, 2017, 23(6):882-896.
|
| 3 |
Rocha V, Wagner JE Jr, Sobocinski KA, et al. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources[J]. N Engl J Med, 2000, 342(25):1846-1854.
|
| 4 |
Mehta RS, Dave H, Bollard CM, et al. Engineering cord blood to improve engraftment after cord blood transplant[J]. Stem Cell Investig, 2017, 4:41.
|
| 5 |
Dehn J, Spellman S, Hurley CK, et al. Selection of unrelated donors and cord blood units for hematopoietic cell transplantation: guidelines from the NMDP/CIBMTR[J]. Blood, 2019, 134(12):924-934.
|
| 6 |
Ghafouri-Fard S, Niazi V, Taheri M, et al. Effect of small molecule on ex vivo expansion of cord blood hematopoietic stem cells: A concise review[J]. Front Cell Dev Biol, 2021, 9:649115.doi: 10.3389/fcell.2021.649115. |
| 7 |
Kadekar D, Kale V, Limaye L. Differential ability of MSCs isolated from placenta and cord as feeders for supporting ex vivo expansion of umbilical cord blood derived CD34(+) cells[J]. Stem Cell Res Ther, 2015, 6:201.doi: 10.1186/s13287-015-0194-y. |
| 8 |
Deans RJ, Moseley AB. Mesenchymal stem cells: biology and potential clinical uses[J]. Exp Hematol, 2000, 28(8):875-884.
|
| 9 |
Mendez-Ferrer S, Michurina TV, Ferraro F, et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche[J]. Nature, 2010, 466(7308):829-834.
|
| 10 |
Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells[J]. Science, 2009, 324(5935):1673-1677.
|
| 11 |
Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells[J]. Nature, 2014, 505(7483):327-334.
|
| 12 |
Szade K, Gulati GS, Chan CKF, et al. Where hematopoietic stem cells live: the bone marrow niche[J]. Antioxid Redox Signal, 2018, 29(2):191-204.
|
| 13 |
Rendra E, Scaccia E, Bieback K. Recent advances in understanding mesenchymal stromal cells[J]. F1000Res, 2020, 9:F1000 Faculty Rev-156. doi: 10.12688/f1000research.21862.1. |
| 14 |
Friedenstein AJ. Stromal mechanisms of bone marrow: cloning in vitro and retransplantation in vivo[J]. Haematol Blood Transfus, 1980, 25:19-29.
|
| 15 |
Klein C, Strobel J, Zingsem J, et al. Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow[J]. Tissue Eng Part A, 2013, 19(23-24):2577-2585.
|
| 16 |
Orticelli V, Papait A, Vertua E, et al. Human amniotic mesenchymal stromal cells support the ex vivo expansion of cord blood hematopoietic stem cells[J]. Stem Cells Transl Med, 2021, 10(11):1516-1529.
|
| 17 |
Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement[J]. Cytotherapy, 2006, 8(4):315-317.
|
| 18 |
Stik G, Crequit S, Petit L, et al. Extracellular vesicles of stromal origin target and support hematopoietic stem and progenitor cells[J]. J Cell Biol, 2017, 216(7):2217-2230.
|
| 19 |
Zhang Y, Chai C, Jiang XS, et al. Co-culture of umbilical cord blood CD34+ cells with human mesenchymal stem cells[J]. Tissue Eng, 2006, 12(8):2161-2170.
|
| 20 |
Lu LL, Liu YJ, Yang SG, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials[J]. Haematologica, 2006, 91(8):1017-1026.
|
| 21 |
Friedman R, Betancur M, Boissel L, et al. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation[J]. Biol Blood Marrow Transplant, 2007, 13(12):1477-1486.
|
| 22 |
Szydlak R. Biological, chemical and mechanical factors regulating migration and homing of mesenchymal stem cells[J]. World J Stem Cells, 2021, 13(6):619-631.
|
| 23 |
Su G, Liu L, Yang L, et al. Homing of endogenous bone marrow mesenchymal stem cells to rat infarcted myocardium via ultrasound-mediated recombinant SDF-1alpha adenovirus in microbubbles[J]. Oncotarget, 2018, 9(1):477-487.
|
| 24 |
Frenette PS, Pinho S, Lucas D, et al. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine[J]. Annu Rev Immunol, 2013, 31:285-316.
|
| 25 |
石蕊，徐曼，苏永峰，等. Notch信号介导共培养脐带间充质干细胞和造血干细胞的相互作用[J]. 细胞与分子免疫学杂志, 2012, 28(8):793-796.
|
| 26 |
Kim A, Shim S, Kim MJ, et al. Mesenchymal stem cell-mediated Notch2 activation overcomes radiation-induced injury of the hematopoietic system[J]. Sci Rep, 2018, 8(1):9277.doi: 10.1038/s41598-018-27666-w. |
| 27 |
Lo Iacono M, Russo E, Anzalone R, et al. Wharton's Jelly mesenchymal stromal cells support the expansion of cord blood-derived CD34(+) cells mimicking a hematopoietic niche in a direct cell-cell contact culture system[J]. Cell Transplant, 2018, 27(1):117-129.
|
| 28 |
Batsali AK, Pontikoglou C, Koutroulakis D, et al. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells[J]. Stem Cell Res Ther, 2017, 8(1):102.doi: 10.1186/s13287-017-0555-9. |
| 29 |
Kadereit S, Deeds LS, Haynesworth SE, et al. Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer[J]. Stem Cells, 2002, 20(6):573-582.
|
| 30 |
Wang JF, Wang LJ, Wu YF, et al. Mesenchymal stem/progenitor cells in human umbilical cord blood as support for ex vivo expansion of CD34(+) hematopoietic stem cells and for chondrogenic differentiation[J]. Haematologica, 2004, 89(7):837-844.
|
| 31 |
Lin HD, Fong CY, Biswas A, et al. Allogeneic human umbilical cord Wharton's jelly stem cells increase several-fold the expansion of human cord blood CD34+ cells both in vitro and in vivo[J]. Stem Cell Res Ther, 2020, 11(1):527.
|
| 32 |
Li Q, Zhao D, Chen Q, et al. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells[J]. Stem Cell Res Ther, 2019, 10(1):376.
|
| 33 |
Oubari F, Amirizade N, Mohammadpour H, et al. The important role of FLT3-L in ex vivo expansion of hematopoietic stem cells following co-culture with mesenchymal stem cells[J]. Cell J, 2015, 17(2):201-210.
|
| 34 |
Ferreira MS, Jahnen-Dechent W, Labude N, et al. Cord blood-hematopoietic stem cell expansion in 3D fibrin scaffolds with stromal support[J]. Biomaterials, 2012, 33(29):6987-6997.
|
| 35 |
Huang X, Zhu B, Wang X, et al. Three-dimensional co-culture of mesenchymal stromal cells and differentiated osteoblasts on human bio-derived bone scaffolds supports active multi-lineage hematopoiesis in vitro: functional implication of the biomimetic HSC niche[J]. Int J Mol Med, 2016, 38(4):1141-1151.
|
| 36 |
Darvish M, Payandeh Z, Soleimanifar F, et al. Umbilical cord blood mesenchymal stem cells application in hematopoietic stem cells expansion on nanofiber three-dimensional scaffold[J]. J Cell Biochem, 2019, 25. doi: 10.1002/jcb.28487. |
| 37 |
Tavakol DN, Tratwal J, Bonini F, et al. Injectable, scalable 3D tissue-engineered model of marrow hematopoiesis[J]. Biomaterials, 2020, 232:119665.doi: 10.1016/j.biomaterials.2019.119665. |
| 38 |
Futrega K, Atkinson K, Lott WB, et al. Spheroid coculture of hematopoietic stem/progenitor cells and monolayer expanded mesenchymal stem/stromal cells in polydimethylsiloxane microwells modestly improves in vitro hematopoietic stem/progenitor cell expansion[J]. Tissue Eng Part C Methods, 2017, 23(4):200-218.
|
| 39 |
Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines[J]. J Extracell Vesicles, 2018, 7(1):1535750.doi: 10.1080/20013078.2018.1535750. |
| 40 |
Jeppesen DK, Fenix AM, Franklin JL, et al. Reassessment of exosome composition[J]. Cell, 2019, 177(2):428-445.e418.
|
| 41 |
Borger V, Bremer M, Ferrer-Tur R, et al. Mesenchymal stem/stromal cell-derived extracellular vesicles and their potential as novel immunomodulatory therapeutic agents[J]. Int J Mol Sci, 2017, 18(7):1450. doi: 10.3390/ijms18071450. |
| 42 |
Abels ER, Breakefield XO. Introduction to extracellular vesicles: biogenesis, RNA cargo selection, content, release, and uptake[J]. Cell Mol Neurobiol, 2016, 36(3):301-312.
|
| 43 |
Abreu SC, Lopes-Pacheco M, Weiss DJ, et al. Mesenchymal stromal cell-derived extracellular vesicles in lung diseases: current status and perspectives[J]. Front Cell Dev Biol, 2021, 9:600711.doi: 10.3389/fcell.2021.600711. |
| 44 |
Ghebes CA, Morhayim J, Kleijer M, et al. Extracellular vesicles derived from adult and fetal bone marrow mesenchymal stromal cells differentially promote ex vivo expansion of hematopoietic stem and progenitor cells[J]. Front Bioeng Biotechnol, 2021, 9:640419.doi: 10.3389/fbioe.2021.640419. |
| 45 |
Xie H, Sun L, Zhang L, et al. Mesenchymal stem cell-derived microvesicles support ex vivo expansion of cord blood-derived CD34(+) cells[J]. Stem Cells Int, 2016, 2016:6493241.doi: 10.1155/2016/6493241. |
| 46 |
Pashoutan Sarvar D, Karimi MH, Movassaghpour A, et al. The effect of mesenchymal stem cell-derived microvesicles on erythroid differentiation of umbilical cord blood-derived CD34(+) Cells[J]. Adv Pharm Bull, 2018, 8(2):291-296.
|
| 47 |
Aqmasheh S, Shamsasenjan K, Khalaf Adeli E, et al. Effect of mesenchymal stem cell-derived microvesicles on megakaryocytic differentiation of CD34(+) hematopoietic stem cells[J]. Adv Pharm Bull, 2020, 10(2):315-322.
|
| 48 |
Jalnapurkar S, Moirangthem RD, Singh S, et al. Microvesicles secreted by nitric oxide-primed mesenchymal stromal cells boost the engraftment potential of hematopoietic stem cells[J]. Stem Cells, 2019, 37(1):128-138.
|
| 49 |
Chen T, Zhang P, Fan W, et al. Co-transplantation with mesenchymal stem cells expressing a SDF-1/HOXB4 fusion protein markedly improves hematopoietic stem cell engraftment and hematogenesis in irradiated mice[J]. Am J Transl Res, 2014, 6(6):691-702.
|
| 50 |
Ajami M, Soleimani M, Abroun S, Atashi A. Comparison of cord blood CD34+ stem cell expansion in coculture with mesenchymal stem cells overexpressing SDF-1 and soluble /membrane isoforms of SCF[J]. J Cell Biochem, 2019, 120(9):15297-15309.
|
| 51 |
Chen W, Li M, Su G, et al. Co-transplantation of hematopoietic stem cells and Cxcr4 gene-transduced mesenchymal stem cells promotes hematopoiesis[J]. Cell Biochem Biophys, 2015, 71(3):1579-1587.
|
| 52 |
Kiani AA, Abdi J, Halabian R, et al. Over expression of HIF-1alpha in human mesenchymal stem cells increases their supportive functions for hematopoietic stem cells in an experimental co-culture model[J]. Hematology, 2014, 19(2):85-98.
|
| 53 |
Arai F, Suda T. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci. 2007, 1106:41-53.
|
| 54 |
Galan-Diez M, Kousteni S. The osteoblastic niche in hematopoiesis and hematological myeloid malignancies[J]. Curr Mol Biol Rep, 2017, 3(2):53-62.
|
| 55 |
Barreto-Duran E, Mejia-Cruz CC, Jaramillo-Garcia LF, et al. 3D multicellular spheroid for the study of human hematopoietic stem cells: synergistic effect between oxygen levels, mesenchymal stromal cells and endothelial cells[J]. J Blood Med, 2021, 12:517-528.
|
| 56 |
Teixeira FG, Salgado AJ. Mesenchymal stem cells secretome: current trends and future challenges[J]. Neural Regen Res, 2020, 15(1):75-77.
|
| 57 |
Romanov YA, Volgina NE, Balashova EE, et al. Human umbilical cord mesenchymal stromal cells support viability of umbilical cord blood hematopoietic stem cells but not the "Stemness" of their progeny in co-culture[J]. Bull Exp Biol Med, 2017, 163(4):523-527.
|
| 58 |
de Lima M, McNiece I, Robinson SN, et al. Cord-blood engraftment with ex vivo mesenchymal-cell coculture[J]. N Engl J Med, 2012, 367(24):2305-2315.
|
| 59 |
Mehta RS, Saliba RM, Cao K, et al. Ex Vivo mesenchymal precursor cell-expanded cord blood transplantation after reduced-intensity conditioning regimens improves time to neutrophil recovery[J]. Biol Blood Marrow Transplant, 2017, 23(8):1359-1366.
|
| 60 |
Congrains A, Bianco J, Rosa RG, et al. 3D scaffolds to model the hematopoietic stem cell niche: applications and perspectives[J]. Materials (Basel), 2021, 14(3):569. doi: 10.3390/ma14030569. |